Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Recursion Pharmaceuticals (RXRX) closed the latest trading day at $5.41, indicating a -1.64% change from the previous session's end. The stock outperformed the S&P 500, which registered a daily ...

One of these two impactful publications was issued by Swiss bank UBS analyst Eliana Merle. She reiterated her buy recommendation on Vertex stock, and kept her $583-per-share price target intact.

President Donald Trump said Tuesday that his administration will soon impose tariffs on pharmaceuticals coming from foreign countries, predicting drug companies will move their operations to the U.S..

President Trump said Tuesday his administration soon would announce “major” tariffs on pharmaceuticals, adding to the tariffs he has already imposed on most goods entering the United States ...

Syros Pharmaceuticals stock opened at $0.02 on Friday. The stock has a market cap of $638,601.60, a P/E ratio of -0.01 and a beta of 1.31. The company has a 50-day moving average price of $0.12 ...

Japanese stock futures trading was briefly suspended Monday morning local time due to a circuit breaker. This came after the Dow Jones and S&P 500 Futures fell 4% each amid fears of a ‘Black ...

(Reuters) - Singapore is negotiating concessions for pharmaceutical exports to the U.S. while ensuring it still has access to high-end AI chips from the American market, said Trade and Deputy ...

LONDON, April 29 (Reuters) - The chief executive of AstraZeneca (AZN.L), opens new tab said on Tuesday that the drugmaker will maintain its 2025 sales guidance even if the U.S. levies tariffs on ...

AUPH has seen some management changes, but activist investors demand more despite steady Lupkynis sales growth. The first quarter was strong in terms of sales in 2023 and 2024, and upcoming Q1 '25 ...

Tonix Pharmaceuticals Stock Down 10.6 % TNXP stock opened at $15.64 on Friday. The firm has a market cap of $100.64 million, a PE ratio of 0.00 and a beta of 2.23. Tonix Pharmaceuticals has a one ...

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Rhythm Pharmaceuticals (RYTM – Research Report), Phio Pharmaceuticals (PHIO – Research Report ...